What are the steps for defibrillation in a patient with ventricular fibrillation or pulseless ventricular tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Defibrillation Steps for Ventricular Fibrillation or Pulseless Ventricular Tachycardia

Early defibrillation with concurrent high-quality CPR is critical to survival when sudden cardiac arrest is caused by ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). 1

Initial Assessment and Preparation

  • Confirm cardiac arrest by checking for responsiveness and absence of normal breathing 1
  • Immediately begin high-quality CPR with chest compressions at a rate of at least 100/minute and a depth of at least 2 inches (5 cm) 1
  • Attach monitor/defibrillator as soon as possible while minimizing interruptions to chest compressions 2
  • Identify VF/pulseless VT on the monitor (disorganized electrical activity without discernible QRS complexes) 2

Defibrillation Protocol

  • For witnessed VF/VT arrest, deliver an immediate unsynchronized shock 1, 2
  • For unwitnessed arrest, consider 2 minutes of CPR before the first shock 1, 2
  • Use appropriate energy settings:
    • For biphasic defibrillators: use manufacturer's recommended dose (typically 120-200J) 2
    • For monophasic defibrillators: use 360J 1, 2
  • Resume CPR immediately after each shock, beginning with chest compressions 1
  • Minimize interruptions in chest compressions, including during rhythm analysis 1
  • After 2 minutes of CPR, reassess rhythm and deliver another shock if VF/VT persists 1

Medication Administration

  • Establish IV/IO access while continuing CPR 2
  • After the first shock and resumption of CPR, administer epinephrine 1mg IV/IO 2
  • Repeat epinephrine every 3-5 minutes during cardiac arrest 2
  • After the second shock and resumption of CPR, consider administering:
    • Amiodarone 300mg IV/IO bolus 3
    • If amiodarone is unavailable, consider lidocaine 1.5mg/kg IV/IO 2
  • For persistent VF/VT, consider a second dose of amiodarone 150mg IV/IO after 3-5 minutes 3

Advanced Airway Management

  • Consider advanced airway placement after initial shocks if personnel are available 2
  • If an advanced airway is placed, deliver 1 breath every 6 seconds (10 breaths/min) with continuous chest compressions 1
  • Use waveform capnography to confirm and monitor endotracheal tube placement 2

Ongoing Management

  • Continue the cycle of CPR-rhythm check-shock (if indicated)-CPR-medications 1
  • Minimize interruptions in chest compressions to less than 10 seconds 1
  • Consider potential reversible causes (Hs and Ts): Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo/hyperkalemia, Hypothermia, Tension pneumothorax, Tamponade, Toxins, Thrombosis 2

Post-Resuscitation Care (if ROSC achieved)

  • Maintain adequate ventilation and oxygenation 2
  • Consider targeted temperature management for patients who do not follow commands after ROSC 1
  • Correct electrolyte abnormalities, particularly potassium and magnesium 2
  • Perform 12-lead ECG and consider cardiac catheterization if indicated 1

Common Pitfalls to Avoid

  • Do not delay defibrillation for witnessed VF/VT arrest 1
  • Avoid excessive interruptions in chest compressions, including for rhythm checks 1
  • Never use synchronized cardioversion for VF (always use unsynchronized shocks) 2
  • Avoid excessive ventilation, which can decrease cardiac output during CPR 2
  • Monitor for potential adverse effects of amiodarone, including hypotension, bradycardia, and hepatic injury 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ventricular Fibrillation Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.